表紙
市場調查報告書

改變遊戲規則的創新為心血管治療帶來變革

Game-changing Innovations Transforming Cardiovascular Care

出版商 Frost & Sullivan 商品編碼 820555
出版日期 內容資訊 英文 44 Pages
商品交期: 最快1-2個工作天內
價格
改變遊戲規則的創新為心血管治療帶來變革 Game-changing Innovations Transforming Cardiovascular Care
出版日期: 2019年03月30日內容資訊: 英文 44 Pages
簡介

本報告調查為心血管治療帶來變革的創新動態,並統整了產業及技術概要、特別是心律調節器、結構式心臟裝置、穿戴式裝置領域的技術創新動態、專利狀況、成長機會、策略必須條件分析等。

第1章 執行摘要

第2章 產業概要、技術概要

  • 重症心血管疾病治療的技術性進步
  • 先進心血管裝置的技術概要
  • 提升電池壽命、電子機器小型化、無線系統進步帶來的心律調節器創新
    • 心跳過緩患者用的小型無鉛心律調節器
    • 對於心律不整患者的低能源植入式去顫療法
    • 對應MRI的植入型心臟裝置
    • 結合醫師與患者的遠端監測心律調節器系統
    • 使心律調節器活性化的無鉛置入物、遠端監測
  • 不需要開胸手術、抗凝血劑的結構式心臟裝置創新
    • 有助於二尖瓣功能改善與逆向重建的植入右側裝置
    • 用於外科上風險高患者的經導管二尖瓣膜修補
    • 用於開放性動脈導管新生兒與早產兒的世界首個小型心臟植入裝置
    • 解決機械性瓣膜、生物瓣膜問題的創新聚合物心臟瓣膜
    • 加速推動臨床實驗的結構性心臟裝置市場在近年的各種交易、契約
    • 技術進步,使得用於高風險患者、年輕患者族群的裝置得以實現
  • 穿戴式心臟裝置技術的??創新:精準度、安全性提升
    • 檢驗出不規則頻率的智慧手錶
    • 具備ECG功能的智慧手錶主要企業
    • AI穿戴式心臟監測器
    • 劃時代的心臟穿戴式技術與資金
    • 擴大各種用途、商業化的業界合作
    • 減輕醫療制度上經濟與資源負擔的心臟穿戴式裝置

第3章 影響評價、成長機會

  • 用於心血管技術企業的新創資金分析
  • NHLBI (National Heart, Lung, and Blood Institute)的技術研究支援
  • 包含心臟瓣膜、心律調節器的最近的臨床實驗評價
  • 心臟穿戴式裝置的臨床實驗評價
  • 專利環境分析:心律調節、結構式心臟裝置、穿戴式裝置
  • 企業別的專利申請動態
  • 成長機會:用於預防性照護的數位&行動技術
  • 未來策略的必須條件

第4章 連絡資訊

目錄
Product Code: D8A2

Minimally Invasive Surgical Interventions & Digital Advances Driving the Future of Cardiac Care

TechVision's latest research service from the medical device technology cluster highlights the game changing innovations in cardiovascular care. Although cardiovascular devices have been in use for decades, over the last few years, there have been some major developments in cardiovascular care. The technology innoavtions are powered by rapid advances in electronics and sensors, especially, digital technologies. The advanced cardiovascular devices are leadless, MRI compatible, intelligent, accurate, miniaturized, remote monitored devices, either wearable or implanted through minimally invasive surgery. This research service showcases the innovations in cardiac pacing devices, structural heart devices as well as cardiac wearables, industry impact, and its growth opportunities.

Table of Contents

1.0 EXECUTIVE SUMMARY

  • 1.1. Scope of the Research
  • 1.2. Research Methodology
  • 1.2. Research Methodology (continued)
  • 1.3. Key Findings

2.0 INDUSTRY OVERVIEW AND TECHNOLOGY SNAPSHOT

  • 2.1. Technology Advancements Fighting Deadly Cardiac Conditions
  • 2.2. Technology Snapshot of Advanced Cardiovascular Devices
  • 2.3. Improvement in Battery Life, Miniaturization of Electronics, and Improved Wireless Systems Revolutionizes the Cardiac Pacing Device
    • 2.3.1. Small, Leadless Pacemaker for Bradycardia Patients
    • 2.3.2. Low-energy Implantable Defibrillation Therapy for Arrhythmia Patients
    • 2.3.3. MRI Compatible Implanted Cardiac Devices Keeping Imaging Modalities Open for Implanted Patients
    • 2.3.4. Remote Monitoring Pacemaker Systems Connecting Physicians and Patients
    • 2.3.5. Leadless Implants, Remote Monitoring Energizing Pacemaker Devices
    • 2.4.0. Innovations in Structural Heart Devices Eliminating Need for Open Heart Surgery and Anti-coagulants
    • 2.4.1. Right-sided Implanted Device Providing Functional Improvement And Reverse Remodeling Of The Mitral Valve
    • 2.4.2. Transcatheter Mitral Valve Repair for High Surgical Risk Patient
    • 2.4.3. World's First Tiny Cardiac Implantable for Patent Ductus Arteriosus Newborns or Premature Infants
    • 2.4.4. Innovative Polymer Based Heart Valve Addressing Issues with Mechanical and Bio prosthetic Valve
    • 2.4.5..Recent Deals in the Structural Heart Device Market to Accelerate its Clinical Trials
    • 2.4.6. Technology Advances Makes Devices Suitable for High Risk and Younger Patient Population
    • 2.5.0. Technology Innovations in Cardiac Wearables Improving Their Accuracy and Safety
    • 2.5.1. Smart Watch for Detecting Irregular Rhythms
    • 2.5.2. Key Players in Cardiac Wearable Industry Smart Watch with ECG capabilities
    • 2.5.3. Artificial Intelligence Powered Wearable Heart Monitors
    • 2.5.4. Funding Backed Breakthrough Cardiac Wearable Technologies
    • 2.5.5. Industry Partnerships to Expand Application and Commercialization
    • 2.5.6. Cardiac Wearables Reducing Economic and Resource Burden on Healthcare system

3.0 IMPACT ASSESSMENT AND GROWTH OPPORTUNITY

  • 3.1.1. Venture Funding Analysis for Cardiovascular Technology Companies
  • 3.1.2. National Heart, Lung, and Blood Institute Supporting Cardiovascular Technology Research
  • 3.2.1. Assessment of Recent Clinical Trial Involving Heart Valves and Pacemaker
  • 3.2.2. Clinical Trial Assessment of Cardiac Wearables
  • 3.3.1. Patent Landscape Analysis of Cardiac Pacing, Structural Heart Device and Cardiac Wearable Innovations
  • 3.3.2. Majority Patents Applications by Cardiac Pacing Device Companies
  • 3.4. Growth Opportunities: Use of Digital and Mobile Technologies for Preventative Cardiovascular Care
  • 3.5. Strategic Imperatives for the Future of Cardiovascular Care Devices

4.0 KEY INDUSTRY CONTACTS

  • 4.1. Key Industry Contacts
  • Legal Disclaimer